mondoBIOTECH holding AG announces today the closing of its share capital increase
mondoBIOTECH holding AG (SIX:RARE) announces today the closing of its share capital increase.
- (1888PressRelease) August 16, 2010 - STANS, Switzerland - The Company has raised CHF 7.4 million. In aggregate, it received subscriptions for 108’755 new shares which corresponds to 84% of the maximum number of shares offered in the Offering, mainly from selected investors.
The first trading day of the newly issued shares is planned to be 13 August 2010, and delivery of the newly issued shares is planned to occur on 16 August 2010.
mondoBIOTECH intends to use the net proceeds of approximately CHF 7 million to fund the further development and commercialization of its medicinal product candidates and for general corporate purposes.
The Company deems the result of the Offering to be a success and considers the fact that considerably more shares than initially planned have been placed with selected investors a clear sign of confidence.
About Mondobiotech
mondoBIOTECH holding AG (SIX Swiss Exchange ticker symbol: RARE), an independent, internet-based biotech research company, discovers drugs for patients suffering from rare and neglected diseases. Mondobiotech has built a continuously growing global community of biologists, biochemists, physicians, patients and patient advocacy organizations who share their passion and skills with Mondobiotech. Together with Mondobiotech, this community is searching for treatments for rare and neglected diseases.
For more information please contact:
mondoBIOTECH holding AG
Investor Relations, Mr. Paolo Bassanini
Das Kloster
Mürgstrasse 18
CH-6370 Stans
Tel.: +41 (0) 840 200 010
Fax: +41 (0) 840 200 011
investor ( @ ) mondobiotech dot com
www.mondobiotech.com
Disclaimer
The foregoing release may contain forward-looking statements. The words “anticipates”, “believes”, “estimates”, “expects”, “intends”, “may”, “plans”, “projects”, “will”, “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. mondoBIOTECH holding AG may not achieve the plans, intentions or expectations disclosed in its forward-looking statements and prospective investors should not place reliance on mondoBIOTECH holding AG’s forward looking statements. There can be no assurance that results of the activities and results of operations will not differ materially from the expectations. Forward- looking statements are subject to inherent risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by or underlying the forward looking statements. mondoBIOTECH holding AG is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
Personal Information
This email is from mondoBIOTECH holding AG. The email and any files transmitted with it are intended solely for the use of the individual or entity to which they are addressed. Any unauthorized dissemination or copying of this email or its attachments, is strictly prohibited and may be illegal. If you have received the email in error please delete it from your system.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam